Curetis
Curetis, FIND Extend Antimicrobial Resistance Research Collaboration
The extended partnership covers the development of an AMR assay, a cartridge for the Unyvero A30 platform, and a software plug-in.
In Brief This Week: Chembio, Gradientech, PerkinElmer, Becton Dickinson, More
News items for the week of April 24, 2023.
FIND, Curetis Ink R&D Collaboration Agreement
FIND and German KfW bank will provide €700,000 ($697,708) to develop the Curetis' Unyvero A30 RQ platform for use in low and middle income countries.
Curetis and European Investment Bank to Restructure Debt Repayment
The EIB plans to restructure debt owed by the OpGen subsidiary Curetis totaling about €13.35 million.
OpGen Q1 Revenues Rise 34 Percent on Combination With Curetis
OpGen said it is awaiting a clearance decision for its Unyvero pneumonia cartridge in China, where it is currently under review and pending approval.
Aug 20, 2020
OpGen Nabs CE-IVD Mark for SARS-CoV-2 Kit
Aug 12, 2020
OpGen Q2 Revenues Climb 20 Percent
May 7, 2020
OpGen Q1 Revenues Drop 38 Percent
Apr 14, 2020
OpGen Q1 Preliminary Revenues Down 38 Percent
Mar 24, 2020
OpGen Fourth Quarter Revenues Increase 8 Percent
Feb 20, 2020
Curetis Preliminary 2019 Revenues Up 64 Percent
Feb 12, 2020